drugset / Trial / NCT04376788

Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19

NCT04376788

Phase 2 Unknown 15 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this project is to introduce way for treatment of patients with severe COVID-19 disease with respiratory complications.

Timeline

Start
2020-05-20
Primary completion
2020-07-01
Completion
2020-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylene Blue Diagnostic / imaging agent 1 mg/kg Intravenous
Subject plasma from convalescent patients with COVID-19 Unknown 200 ml Intravenous

Indications